BioSpace News Archive

Hercules Capital, Inc. announced its financial results for the first quarter ended March 31, 2018.

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it will utilize the Therapeutic Development Services funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to conduct further preclinical studies of AB-SA01

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced that Senior Vice President and Chief Business Officer, Curt A. Herberts, III will resign from the Company effective June 1, 2018 to pursue a leadership opportunity with a private biotech company.

Select Medical Holdings Corporation announced results for its first quarter ended March 31, 2018.

Zimmer Biomet Holdings, Inc. announced that it will be participating in the Deutsche Bank 43rd Annual Health Care Conference.

Allergan plc announced that John Davidson has been elected to its Board of Directors.

Second Sight Medical Products, Inc. will release its 2018 first quarter financial results on Thursday, May 10, 2018

SciCan is proud to announce SALUS, the world’s first paperless rack & sleeve dental hygiene instrument sterility maintenance container.

Medidata is pleased to announce that its director of strategic accounts and medical device/diagnostic sales, Melinda Pautsch, has been named a 2018 “Rising Star” by the Healthcare Businesswomen’s Association (HBA).

SciCan, Inc. is proud to welcome John Mudd to the newly created position of Sales Representative, Infection Control in Los Angeles, CA.